Global Oncolytic Virus Market Growth 2022-2028
As the global economy mends, the 2021 growth of Oncolytic Virus will have significant change from previous year. According to our latest study, the global Oncolytic Virus market size is USD million in 2022 from USD 17 million in 2021, with a change of % between 2021 and 2022. The global Oncolytic Virus market size will reach USD 27 million in 2028, growing at a CAGR of 7.1% over the analysis period.
The United States Oncolytic Virus market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oncolytic Virus market, reaching US$ million by the year 2028. As for the Europe Oncolytic Virus landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oncolytic Virus players cover Amgen, Shanghai Sunway Biotech, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Imlygic
Oncorine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Melanoma
Other Cancers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amgen
Shanghai Sunway Biotech
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oncolytic Virus by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oncolytic Virus by Country/Region, 2017, 2022 & 2028
2.2 Oncolytic Virus Segment by Type
2.2.1 Imlygic
2.2.2 Oncorine
2.2.3 Others
2.3 Oncolytic Virus Sales by Type
2.3.1 Global Oncolytic Virus Sales Market Share by Type (2017-2022)
2.3.2 Global Oncolytic Virus Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oncolytic Virus Sale Price by Type (2017-2022)
2.4 Oncolytic Virus Segment by Application
2.4.1 Melanoma
2.4.2 Other Cancers
2.5 Oncolytic Virus Sales by Application
2.5.1 Global Oncolytic Virus Sale Market Share by Application (2017-2022)
2.5.2 Global Oncolytic Virus Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oncolytic Virus Sale Price by Application (2017-2022)
3 Global Oncolytic Virus by Company
3.1 Global Oncolytic Virus Breakdown Data by Company
3.1.1 Global Oncolytic Virus Annual Sales by Company (2020-2022)
3.1.2 Global Oncolytic Virus Sales Market Share by Company (2020-2022)
3.2 Global Oncolytic Virus Annual Revenue by Company (2020-2022)
3.2.1 Global Oncolytic Virus Revenue by Company (2020-2022)
3.2.2 Global Oncolytic Virus Revenue Market Share by Company (2020-2022)
3.3 Global Oncolytic Virus Sale Price by Company
3.4 Key Manufacturers Oncolytic Virus Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncolytic Virus Product Location Distribution
3.4.2 Players Oncolytic Virus Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oncolytic Virus by Geographic Region
4.1 World Historic Oncolytic Virus Market Size by Geographic Region (2017-2022)
4.1.1 Global Oncolytic Virus Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oncolytic Virus Annual Revenue by Geographic Region
4.2 World Historic Oncolytic Virus Market Size by Country/Region (2017-2022)
4.2.1 Global Oncolytic Virus Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oncolytic Virus Annual Revenue by Country/Region
4.3 Americas Oncolytic Virus Sales Growth
4.4 APAC Oncolytic Virus Sales Growth
4.5 Europe Oncolytic Virus Sales Growth
4.6 Middle East & Africa Oncolytic Virus Sales Growth
5 Americas
5.1 Americas Oncolytic Virus Sales by Country
5.1.1 Americas Oncolytic Virus Sales by Country (2017-2022)
5.1.2 Americas Oncolytic Virus Revenue by Country (2017-2022)
5.2 Americas Oncolytic Virus Sales by Type
5.3 Americas Oncolytic Virus Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Sales by Region
6.1.1 APAC Oncolytic Virus Sales by Region (2017-2022)
6.1.2 APAC Oncolytic Virus Revenue by Region (2017-2022)
6.2 APAC Oncolytic Virus Sales by Type
6.3 APAC Oncolytic Virus Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oncolytic Virus by Country
7.1.1 Europe Oncolytic Virus Sales by Country (2017-2022)
7.1.2 Europe Oncolytic Virus Revenue by Country (2017-2022)
7.2 Europe Oncolytic Virus Sales by Type
7.3 Europe Oncolytic Virus Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncolytic Virus by Country
8.1.1 Middle East & Africa Oncolytic Virus Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oncolytic Virus Revenue by Country (2017-2022)
8.2 Middle East & Africa Oncolytic Virus Sales by Type
8.3 Middle East & Africa Oncolytic Virus Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncolytic Virus
10.3 Manufacturing Process Analysis of Oncolytic Virus
10.4 Industry Chain Structure of Oncolytic Virus
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncolytic Virus Distributors
11.3 Oncolytic Virus Customer
12 World Forecast Review for Oncolytic Virus by Geographic Region
12.1 Global Oncolytic Virus Market Size Forecast by Region
12.1.1 Global Oncolytic Virus Forecast by Region (2023-2028)
12.1.2 Global Oncolytic Virus Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncolytic Virus Forecast by Type
12.7 Global Oncolytic Virus Forecast by Application
13 Key Players Analysis
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Oncolytic Virus Product Offered
13.1.3 Amgen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Oncolytic Virus Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oncolytic Virus Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Imlygic
Table 4. Major Players of Oncorine
Table 5. Major Players of Others
Table 6. Global Oncolytic Virus Sales by Type (2017-2022) & (K Units)
Table 7. Global Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 8. Global Oncolytic Virus Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oncolytic Virus Revenue Market Share by Type (2017-2022)
Table 10. Global Oncolytic Virus Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 12. Global Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 13. Global Oncolytic Virus Revenue by Application (2017-2022)
Table 14. Global Oncolytic Virus Revenue Market Share by Application (2017-2022)
Table 15. Global Oncolytic Virus Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Oncolytic Virus Sales by Company (2020-2022) & (K Units)
Table 17. Global Oncolytic Virus Sales Market Share by Company (2020-2022)
Table 18. Global Oncolytic Virus Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oncolytic Virus Revenue Market Share by Company (2020-2022)
Table 20. Global Oncolytic Virus Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Oncolytic Virus Producing Area Distribution and Sales Area
Table 22. Players Oncolytic Virus Products Offered
Table 23. Oncolytic Virus Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oncolytic Virus Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Oncolytic Virus Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oncolytic Virus Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oncolytic Virus Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oncolytic Virus Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Oncolytic Virus Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oncolytic Virus Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oncolytic Virus Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 35. Americas Oncolytic Virus Sales Market Share by Country (2017-2022)
Table 36. Americas Oncolytic Virus Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oncolytic Virus Revenue Market Share by Country (2017-2022)
Table 38. Americas Oncolytic Virus Sales by Type (2017-2022) & (K Units)
Table 39. Americas Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 40. Americas Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 41. Americas Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 42. APAC Oncolytic Virus Sales by Region (2017-2022) & (K Units)
Table 43. APAC Oncolytic Virus Sales Market Share by Region (2017-2022)
Table 44. APAC Oncolytic Virus Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oncolytic Virus Revenue Market Share by Region (2017-2022)
Table 46. APAC Oncolytic Virus Sales by Type (2017-2022) & (K Units)
Table 47. APAC Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 48. APAC Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 49. APAC Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 50. Europe Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 51. Europe Oncolytic Virus Sales Market Share by Country (2017-2022)
Table 52. Europe Oncolytic Virus Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oncolytic Virus Revenue Market Share by Country (2017-2022)
Table 54. Europe Oncolytic Virus Sales by Type (2017-2022) & (K Units)
Table 55. Europe Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 56. Europe Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 57. Europe Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Oncolytic Virus Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oncolytic Virus Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oncolytic Virus Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oncolytic Virus Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oncolytic Virus
Table 67. Key Market Challenges & Risks of Oncolytic Virus
Table 68. Key Industry Trends of Oncolytic Virus
Table 69. Oncolytic Virus Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oncolytic Virus Distributors List
Table 72. Oncolytic Virus Customer List
Table 73. Global Oncolytic Virus Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Oncolytic Virus Sales Market Forecast by Region
Table 75. Global Oncolytic Virus Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oncolytic Virus Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oncolytic Virus Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Oncolytic Virus Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oncolytic Virus Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Oncolytic Virus Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oncolytic Virus Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Oncolytic Virus Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oncolytic Virus Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Oncolytic Virus Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oncolytic Virus Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Oncolytic Virus Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oncolytic Virus Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oncolytic Virus Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oncolytic Virus Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Oncolytic Virus Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oncolytic Virus Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oncolytic Virus Revenue Market Share Forecast by Application (2023-2028)
Table 93. Amgen Basic Information, Oncolytic Virus Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Oncolytic Virus Product Offered
Table 95. Amgen Oncolytic Virus Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. Shanghai Sunway Biotech Basic Information, Oncolytic Virus Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Sunway Biotech Oncolytic Virus Product Offered
Table 100. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Shanghai Sunway Biotech Main Business
Table 102. Shanghai Sunway Biotech Latest Developments
List of Figures
Figure 1. Picture of Oncolytic Virus
Figure 2. Oncolytic Virus Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncolytic Virus Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oncolytic Virus Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oncolytic Virus Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Imlygic
Figure 10. Product Picture of Oncorine
Figure 11. Product Picture of Others
Figure 12. Global Oncolytic Virus Sales Market Share by Type in 2021
Figure 13. Global Oncolytic Virus Revenue Market Share by Type (2017-2022)
Figure 14. Oncolytic Virus Consumed in Melanoma
Figure 15. Global Oncolytic Virus Market: Melanoma (2017-2022) & (K Units)
Figure 16. Oncolytic Virus Consumed in Other Cancers
Figure 17. Global Oncolytic Virus Market: Other Cancers (2017-2022) & (K Units)
Figure 18. Global Oncolytic Virus Sales Market Share by Application (2017-2022)
Figure 19. Global Oncolytic Virus Revenue Market Share by Application in 2021
Figure 20. Oncolytic Virus Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Oncolytic Virus Revenue Market Share by Company in 2021
Figure 22. Global Oncolytic Virus Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Oncolytic Virus Revenue Market Share by Geographic Region in 2021
Figure 24. Global Oncolytic Virus Sales Market Share by Region (2017-2022)
Figure 25. Global Oncolytic Virus Revenue Market Share by Country/Region in 2021
Figure 26. Americas Oncolytic Virus Sales 2017-2022 (K Units)
Figure 27. Americas Oncolytic Virus Revenue 2017-2022 ($ Millions)
Figure 28. APAC Oncolytic Virus Sales 2017-2022 (K Units)
Figure 29. APAC Oncolytic Virus Revenue 2017-2022 ($ Millions)
Figure 30. Europe Oncolytic Virus Sales 2017-2022 (K Units)
Figure 31. Europe Oncolytic Virus Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Oncolytic Virus Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Oncolytic Virus Revenue 2017-2022 ($ Millions)
Figure 34. Americas Oncolytic Virus Sales Market Share by Country in 2021
Figure 35. Americas Oncolytic Virus Revenue Market Share by Country in 2021
Figure 36. United States Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Oncolytic Virus Sales Market Share by Region in 2021
Figure 41. APAC Oncolytic Virus Revenue Market Share by Regions in 2021
Figure 42. China Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Oncolytic Virus Sales Market Share by Country in 2021
Figure 49. Europe Oncolytic Virus Revenue Market Share by Country in 2021
Figure 50. Germany Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Oncolytic Virus Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Oncolytic Virus Revenue Market Share by Country in 2021
Figure 57. Egypt Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Oncolytic Virus Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Oncolytic Virus in 2021
Figure 63. Manufacturing Process Analysis of Oncolytic Virus
Figure 64. Industry Chain Structure of Oncolytic Virus
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
